HC Wainwright reaffirmed their buy rating on shares of Rockwell Medical (NASDAQ:RMTI – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. HC Wainwright currently has a $9.00 price target on the stock. HC Wainwright also issued estimates for Rockwell Medical’s FY2025 earnings at $0.04 EPS. Rockwell Medical Trading Up […]

Related Keywords

, Great Valley Advisor Group Inc , Raymond James Associates , Skyoak Wealth , Rockwell Medical Inc , Clarivest Asset Management , Wealthtrust Axiom , Rockwell Medical , Free Report , Get Free Report , Valley Advisor Group , Oak Wealth , Trust Axiom , Vest Asset Management , Raymond James , Triferic Dialysate , Rockwell Medical Daily ,